Ci Investments Inc. Vertex Pharmaceuticals Inc Transaction History

Ci Investments Inc.

$26.3 Billion
Q3 2024

A detailed history of Ci Investments Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ci Investments Inc. holds 53,926 shares of VRTX stock, worth $21.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

53,926

Previous 13,428 301.59%

Holding current value

$21.4 Million

Previous $6.29 Million 298.47%

% of portfolio

0.1%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$460.0 - $505.78 $18.6 Million - $20.5 Million	40,498 Added 301.59%	53,926 $25.1 Million
Q2 2024 Aug 12, 2024	BUY	$392.81 - $485.53 $1.43 Million - $1.77 Million	3,640 Added 37.19%	13,428 $6.29 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $1.23 Million - $1.35 Million	3,025 Added 44.73%	9,788 $4.09 Million
Q4 2023 Feb 12, 2024	SELL	$343.0 - $410.68 $325,850 - $390,146	-950 Reduced 12.32%	6,763 $2.75 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $173,148 - $185,579	-512 Reduced 6.22%	7,713 $2.68 Million
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $385,478 - $431,441	-1,226 Reduced 12.97%	8,225 $2.9 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $491,970 - $561,224	1,737 Added 22.52%	9,451 $2.98 Million
Q4 2022 Feb 10, 2023	BUY	$285.76 - $321.48 $100,016 - $112,518	350 Added 4.75%	7,714 $2.23 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $465,784 - $519,706	1,701 Added 30.04%	7,364 $2.13 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $182,563 - $227,311	-777 Reduced 12.07%	5,663 $1.6 Million
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $122,002 - $143,794	551 Added 9.36%	6,440 $1.68 Million
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $40,712 - $51,393	230 Added 4.06%	5,889 $1.29 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $270,633 - $302,861	1,492 Added 35.81%	5,659 $1.03 Million
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $323,982 - $382,060	-1,728 Reduced 29.31%	4,167 $840,000
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $351,312 - $409,503	1,697 Added 40.42%	5,895 $1.27 Million
Q4 2020 Feb 09, 2021	SELL	$207.01 - $276.09 $18,837 - $25,124	-91 Reduced 2.12%	4,198 $992,000
Q3 2020 Nov 09, 2020	SELL	$255.65 - $303.1 $58,032 - $68,803	-227 Reduced 5.03%	4,289 $1.17 Million
Q2 2020 Aug 07, 2020	BUY	$225.48 - $295.8 $153,100 - $200,848	679 Added 17.7%	4,516 $1.31 Million
Q1 2020 Aug 07, 2020	BUY	$199.77 - $247.81 $543,374 - $674,043	2,720 Added 243.51%	3,837 $913,000
Q4 2019 Feb 11, 2020	BUY	$166.71 - $223.91 $166,710 - $223,910	1,000 Added 854.7%	1,117 $245,000
Q3 2019 Nov 08, 2019	BUY	$166.23 - $187.09 $19,448 - $21,889	117 New	117 $20,000
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $114,611 - $136,290	-700 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$151.91 - $192.21 $106,337 - $134,547	700 New	700 $115,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.

Account

Ci Investments Inc. Vertex Pharmaceuticals Inc Transaction History